Hepatitis B Vaccine (Recombinant) Market Report

Global and China Hepatitis B Vaccine (Recombinant) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 04, 2022
  • PAGES：200
  • REPORT CODE：GMM1344292
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Hepatitis B Vaccine (Recombinant) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Serum Institute

    • LG Life Sciences

    • GSK

    • Dynavax Technologies

    • KM Biologics

    • Shenzhen Kangtai Biological Products

    • Merck

    • Sanofi Pasteur

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • 10mcg/05ml

    • 10mcg/ml

    Application:

    • Newborn

    • Adult

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hepatitis B Vaccine (Recombinant) Industry Overview

      • 1.1.1 Hepatitis B Vaccine (Recombinant) Market Scope and Market Segments

      • 1.1.2 Hepatitis B Vaccine (Recombinant) Industry Characteristics

      • 1.1.3 Global and China Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hepatitis B Vaccine (Recombinant) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 10mcg/05ml

      • 1.2.2 10mcg/ml

    • 1.3 Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Newborn

      • 1.3.2 Adult

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hepatitis B Vaccine (Recombinant) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hepatitis B Vaccine (Recombinant) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hepatitis B Vaccine (Recombinant) Industry PEST Analysis

    • 2.3 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hepatitis B Vaccine (Recombinant) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hepatitis B Vaccine (Recombinant) Industry

    Chapter 3 Global and China Hepatitis B Vaccine (Recombinant) Market, by Manufacturer

    • 3.1 Global and China Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hepatitis B Vaccine (Recombinant) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hepatitis B Vaccine (Recombinant) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hepatitis B Vaccine (Recombinant) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hepatitis B Vaccine (Recombinant) Market Top 3 Players

    Chapter 4 Global and China Hepatitis B Vaccine (Recombinant) Market, by Type (2017-2028)

    • 4.1 Hepatitis B Vaccine (Recombinant) Market Trend, by Type

    • 4.2 Global Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hepatitis B Vaccine (Recombinant) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hepatitis B Vaccine (Recombinant) Price Trend, by Type (2017-2028)

    • 4.3 China Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hepatitis B Vaccine (Recombinant) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hepatitis B Vaccine (Recombinant) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hepatitis B Vaccine (Recombinant) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hepatitis B Vaccine (Recombinant) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hepatitis B Vaccine (Recombinant) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hepatitis B Vaccine (Recombinant) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hepatitis B Vaccine (Recombinant) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hepatitis B Vaccine (Recombinant) Market Analysis

    • 7.1 North America Hepatitis B Vaccine (Recombinant) Market, by Type

    • 7.2 North America Hepatitis B Vaccine (Recombinant) Market, by Application

    • 7.3 North America Hepatitis B Vaccine (Recombinant) Market Analysis and Forecast, by Country

      • 7.3.1 United States Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hepatitis B Vaccine (Recombinant) Market Analysis

    • 8.1 Europe Hepatitis B Vaccine (Recombinant) Market, by Type

    • 8.2 Europe Hepatitis B Vaccine (Recombinant) Market, by Application

    • 8.3 Europe Hepatitis B Vaccine (Recombinant) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hepatitis B Vaccine (Recombinant) Market Analysis

    • 9.1 APAC Hepatitis B Vaccine (Recombinant) Market, by Type

    • 9.2 APAC Hepatitis B Vaccine (Recombinant) Market, by Application

    • 9.3 APAC Hepatitis B Vaccine (Recombinant) Market Analysis and Forecast, by Country

      • 9.3.1 China Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Analysis

    • 10.1 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Market, by Type

    • 10.2 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Market, by Application

    • 10.3 Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hepatitis B Vaccine (Recombinant) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hepatitis B Vaccine (Recombinant) Company Profiles

      • 11.1 Serum Institute

        • 11.1.1 Serum Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.1.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 LG Life Sciences

        • 11.2.1 LG Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.2.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 GSK

        • 11.3.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 GSK Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.3.3 GSK Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Dynavax Technologies

        • 11.4.1 Dynavax Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 KM Biologics

        • 11.5.1 KM Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.5.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Shenzhen Kangtai Biological Products

        • 11.6.1 Shenzhen Kangtai Biological Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.6.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Merck

        • 11.7.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Merck Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.7.3 Merck Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Sanofi Pasteur

        • 11.8.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Profiles, Application and Specification

        • 11.8.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hepatitis B Vaccine (Recombinant) Industry Investment Prospect and Risk Assessment

    • 12.1 Hepatitis B Vaccine (Recombinant) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hepatitis B Vaccine (Recombinant) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Production Value and Growth Rate (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Production Value and Growth Rate (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate of 10mcg/05ml (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate of 10mcg/ml (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate of Newborn (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate of Adult (2017-2028)

    • Figure North America Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hepatitis B Vaccine (Recombinant) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hepatitis B Vaccine (Recombinant) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hepatitis B Vaccine (Recombinant) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hepatitis B Vaccine (Recombinant) Market Share, by Manufacturer in 2021

    • Figure Global and China Hepatitis B Vaccine (Recombinant) Market Share, by Manufacturer in 2022

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Value, by Type (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Value Share, by Type (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Price Trend, by Type (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Value, by Type (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Value Share, by Type (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Price Trend, by Type (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Value, by Application (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Sales Value Share, by Application (2017-2028)

    • Figure Global Hepatitis B Vaccine (Recombinant) Sales Value Share, by Application (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Value, by Application (2017-2028)

    • Table China Hepatitis B Vaccine (Recombinant) Sales Value Share, by Application (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Value Share, by Application (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Production, Import, Consumption and Export (2017-2022)

    • Table North America Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table North America Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure North America Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table North America Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table North America Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure North America Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure United States Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Table Europe Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table Europe Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table Europe Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table Europe Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure UK Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure France Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure France Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Table APAC Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table APAC Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table APAC Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table APAC Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure India Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure India Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hepatitis B Vaccine (Recombinant) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hepatitis B Vaccine (Recombinant) Sales Value and Growth Rate (2017-2028)

    • Table Serum Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute Product Profiles, Application and Specification

    • Table Serum Institute Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LG Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LG Life Sciences Product Profiles, Application and Specification

    • Table LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dynavax Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dynavax Technologies Product Profiles, Application and Specification

    • Table Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table KM Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table KM Biologics Product Profiles, Application and Specification

    • Table KM Biologics Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shenzhen Kangtai Biological Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shenzhen Kangtai Biological Products Product Profiles, Application and Specification

    • Table Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US